Medically reviewed by Lindsey Waldman, MD, RD A C. diff (Clostridioides difficile ) diet may help alleviate diarrhea (the ...

In a small randomized trial, people who took capsules containing donated gut microbiomes experienced fewer gastrointestinal ...

Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia as oral therapies for gastrointestinal diseases, today announced the publication of additional results from ...

The antibody drug, Zinplava, was first approved by the regulator in 2016 to prevent the recurrence of Clostridioides difficile infections (CDI). CDI is generally caused by prolonged use of ...

Nosocomial Clostridioides difficile infections were linked to higher mortality, longer hospital stays, and increased ...

Pfizer hosted a discussion with sell-side analysts to provide an update on one of the vaccine pipeline items – a second-generation Clostridioides difficile (C. diff) vaccine effort in Phase 2.

The panelist discusses how recurrent Clostridioides difficile infection significantly increases health care costs through prolonged hospitalizations, complex treatments, and elevated medical resource ...

Contrasting methods to operationalize antibiotic exposure in clinical research: a real-world application on healthcare-associated Clostridioides difficile infection. Am J Epidemiol. 2024 Aug ...